Gyre Therapeutics, Inc. Finite-Lived Patents, Gross
Gyre Therapeutics, Inc. (GYRE) had Finite-Lived Patents, Gross of $296.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FiniteLivedPatentsGross · last filed 2016-03-09
- 2014-12-31: Finite-Lived Patents, Gross $296.00K.
- 2013-12-31: Finite-Lived Patents, Gross $296.00K.
- 2012-12-31: Finite-Lived Patents, Gross $296.00K.
- 2011-12-31: Finite-Lived Patents, Gross $296.00K.
| Period end | Finite-Lived Patents, Gross | Finite-Lived Patents, Gross as first filed |
|---|---|---|
| 2014-12-31 | $296.00K 10-K · filed 2015-03-16 | |
| 2013-12-31 | $296.00K 10-K · filed 2015-03-16 | |
| 2012-12-31 | $296.00K 10-K · filed 2014-03-14 | |
| 2011-12-31 | $296.00K 10-K · filed 2013-03-15 | |
| 2009-12-31 | $100.00K 10-K · filed 2016-03-09 | $70.57K 8-K/A · filed 2015-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |